Page 30 - Vaccine

Govt push to step up Covid-19 vaccine output 10 times by September

Bharat Biotech and 3 PSEs to ramp up Covaxin production capacity

Best of BS Opinion: Rise of risk capital, Covid-19 vaccination, and more

Here's a selection of Business Standard opinion pieces for the day

Decision in 3 working days after foreign Covid-19 vaccine firms apply

Many vaccine makers in talks with govt as India wants a portfolio of products

The supply side

Ramping up vaccine availability has become critical

Coping with Covid

We need to stop messing around and plan ahead of the infection curve

Shortage of key chemical hits Bharat Biotech's Covaxin ramp-up plans

Bharat Biotech is trying to ramp up capacities of Covaxin to 12 million doses per month by July, from the current 5 million doses per month

Best of BS Opinion: The mis-selling menace, Covid-19 vaccination, and more

Here's a selection of Business Standard opinion pieces for the day

Govt slams states: No Covid-19 vaccine shortage, only poor planning

Rajesh Bhushan, Union health secretary, said that there were over 20 million doses in the pipeline to be distributed to states

Vaccination drive: An Utsav without utsah

After watching the government mess up its handling of Covid, people want a strategy, not participatory stunts

Right prescription

Fast-tracking of vaccine approvals is a welcome policy change

Fast-track Covid-19 vaccine approval gives indices a shot in the arm

Sensex, Nifty rise 1.4%; experts see volatility continuing in near term

India gets third Covid-19 vaccine as SEC clears Russia's Sputnik V

Final nod from DCGI soon, jab likely at $3/dose

Failure on vaccines

Refusal to support private sector has led to a roll-out flop

Covid-19 vaccination sites drop to half in India amid shortage of doses

Number of locations down from 120,000 to 60,000 from April 3 to 7

India drug regulator asks Dr Reddy's for more data on Sputnik V vaccine

The committee asked the company to submit a comparative analysis of late-stage immunogenicity data from both its Indian studies and an ongoing Russian study

ICU beds: Maharashtra struggles, others fare better as Covid-19 cases rise

At Maharashtra, the epicentre of the second wave of Covid-19 in India, the health infrastructure is facing a fresh challenge as cases multiply

AstraZeneca has sent us legal notice for vaccine supply delay: Poonawalla

For the next one or two months, we will be prioritising supplies only to India based on the request of the government and also depending on the needs of our people, said Poonawalla

SII to start supplying 1st India-made pneumococcal conjugate jab to govt

The Serum Institute of India (SII) will start supplying the first indigenously developed pneumococcal conjugate vaccine to the Centre from Wednesday, sources said on Tuesday

Fruit vendors, security services exempted as Maharashtra revises guidelines

Petrol pumps, govt and private security services, and fruit vendors among others have been added to the list of essential services in Maharashtra

15 million doses of J&J coronavirus vaccine ruined in US by 'human error'

Errors at a manufacturing plant in the US has ruined 15 million potential doses of the Johnson & Johnson Covid-19 vaccine, The New York Times reported.